The effect of screen time on nighttime urinary incontinence

The effect of screen time on the presentation and treatment of primary monosymptomatic nocturnal enuresis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15760867

Enrollment

Registered

2022-05-23

Start date

2021-03-15

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary monosymptomatic enuresis Urological and Genital Diseases

Interventions

1. After a diagnosis of primary monosymptomatic nocturnal enuresis, classified as mild (1-2 wet nights/week), moderate (3-5 wet nights/week) and severe (6-7 wet nights/week), patients were separated b

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 6 to 18 years 2. Diagnosed as primary monosymptomatic enuresis nocturna as a result of history, physical examination and routine tests 3. Have not had an operation due to urinary system pathologies before 4. A body mass index below the 95th percentile 5. Screen exposure of different durations 6. Caregivers or patients who can keep a voiding diary, nighttime bedwetting chart

Exclusion criteria

Exclusion criteria: 1. A diagnosis with secondary enuresis and non-monosymptomatic nocturnal enuresis 2. Previously treated for nocturnal enuresis 3. Neurological disease, obstructive respiratory diseases and diabetes mellitus 4. Previously diagnosed neurogenic bladder, vesicoureteral reflux, urinary system stone disease 5. Previous surgery due to urinary pathology 6. A body mass index above the 95th percentile 7. Caregivers or patients who cannot keep a voiding diary, nighttime bedwetting chart

Design outcomes

Primary

Measure	Time frame
Treatment response measured by the dryness of a child’s sleeping quarters recorded daily on waking, defined as a full response at 100% dryness, a partial response at 50-99% dryness, or a failure at <50% dryness at month 3. Patients in groups 3 and 4 with a full response had their DeM treatment terminated and recurrence, defined by one or more night-time bed wetting events in month 4, was determined at a follow-up visit at the end of month 4.	—

Measure

Time frame

Treatment response measured by the dryness of a child’s sleeping quarters recorded daily on waking, defined as a full response at 100% dryness, a partial response at 50-99% dryness, or a failure at <50% dryness at month 3. Patients in groups 3 and 4 with a full response had their DeM treatment terminated and recurrence, defined by one or more night-time bed wetting events in month 4, was determined at a follow-up visit at the end of month 4.

—

Secondary

Measure	Time frame
Late recurrence, defined by one or more night-time bed wetting events from month 4 and measured daily on waking, was recorded at a 6-month long-term follow-up visit.	—

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 10, 2026